HPV相关口咽癌接受TORS三联治疗的生存与毒性
本研究回顾性分析2010至2017年接受经口机器人手术(TORS)三联治疗的178例HPV相关口咽鳞癌(HPV+OPSCC)患者,5年生存率达93.6%,治疗完成时喂养管使用率为25.8%,1年时降至0.7%,顺铂治疗者≥3级肾损伤、贫血和中性粒细胞减少发生率分别为2.7%、3.4%和11.0%,提示该方案生存极佳且毒性及喂养管依赖率低。
要点
- HPV+OPSCC接受TORS三联治疗5年生存率达93.6%。
- 治疗完成时喂养管率25.8%,1年时仅0.7%。
- 顺铂治疗者≥3级中性粒细胞减少发生率11.0%。
核心结论
- HPV+OPSCC患者接受TORS三联治疗生存极佳,毒性和喂养管依赖率低,优于历史放化疗队列。
研究设计与样本
- 回顾性队列研究,纳入2010至2017年单中心连续接受TORS三联治疗的178例HPV+OPSCC患者,采用Kaplan-Meier法估计生存,通过病历回顾确定毒性。
主要发现
- 5年生存率为93.6%。
- 治疗完成时喂养管率为25.8%,1年时为0.7%。
- 顺铂治疗患者≥3级肾损伤、贫血和中性粒细胞减少发生率分别为2.7%、3.4%和11.0%。
临床怎么用
- 对于具有高危特征的HPV+OPSCC患者,TORS三联治疗可作为生存获益好且毒性可接受的选项。
局限性
- 回顾性设计、单中心、样本量有限,毒性通过病历回顾确定可能存在漏报。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with oropharyngeal cancer who undergo transoral robotic surgery (TORS) and have high-risk features generally receive adjuvant chemoradiotherapy or trimodality therapy (TMT). The notion that TMT leads to high toxicity is largely based on studies that included human papilloma virus (HPV)-negative cancers and/or nonrobotic surgery; we sought to describe outcomes in HPV-associated oropharyngeal squamous cell cancer (HPV + OPSCC) undergoing TORS-TMT. METHODS: In consecutive patients with HPV + OPSCC receiving TMT at an academic center from 2010 to 2017, survival was estimated using Kaplan-Meier methodology, and toxicities were ascertained via chart review. RESULTS: In our cohort of 178 patients, 5-year survival was 93.6%. Feeding tube rates were 25.8% at therapy completion and 0.7% at 1 year. Rates of grade ≥ 3 kidney injury, anemia, and neutropenia in cisplatin-treated patients were 2.7%, 3.4%, and 11.0%, respectively. CONCLUSIONS: Patients with HPV + OPSCC who underwent TORS-TMT had excellent survival and low rates of toxicity and feeding tube dependence. These outcomes compare favorably to historical cohorts treated with definitive chemoradiotherapy.
引用
- Sun L, Shimunov D, Tan EX, et al. Survival and toxicity in patients with human papilloma virus-associated oropharyngeal squamous cell cancer receiving trimodality therapy including transoral robotic surgery. Head Neck. 2021. PMID: 34170052. doi:10.1002/hed.26797
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。